The biotech sector witnessed a see-saw performance in 2024. Though the year started on a positive note, those gains were ...

Noida: After three years of deliberations, revisions, approvals and re-approvals – hectic conference room activity that ...

India's new drug approval process waiver raises concerns about patient safety, research, and healthcare implications, experts ...